
Renal diagnostic dev RenalytixAI closes $29m IPO
AI-powered kidney disease and transplant management diagnostic developer RenalytixAI said this week it completed an $29 million initial public offering on the London Stock Exchange’s Alternative Investment Market. The company was formed through an …